Recently, studies showed a promising counter-fight: mesenchymal stem cells -3TSR/s-TRAIL inhibiting effects over GBM progression by modulating both tumor cells and endothelial cells [97]. The gene discussed is TNFSF10; the disease is glioblastoma.